Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2020

View Archived Issues

Capsid-like particles displaying an HA trimer: a promising universal flu vaccine candidate

New partner in crime for AHR

Multiple sclerosis' early days

New ADCs including tandem-cleavage linkers show improved stability and toxicity

Epigenetic problems contribute to Parkinson's disease

Roche reports the discovery of novel CYP11B2 inhibitors

Tocilizumab may prevent risk of invasive mechanical ventilation or death in severe COVID-19

Bayer, The Broad Institute describe new PDE3A and/or PDE3B inhibitors

FDA clears IND application for phase Ib study of NT-I7 plus Kymriah in r/r LBCL

Positive topline data presented from phase III CONTESSA study of tesetaxel

Orexin receptor type 1 antagonists discovered at Heptares Therapeutics

Hubei Bio-Pharmaceutical, Humanwell Healthcare patent E-NPP 2 inhibitors

Bristol-Myers Squibb discovers TYK2 inhibitors

New adenosine A2A/A2B receptor antagonists identified at Incyte

Pivotal phase III INSPIRE study of rigosertib in MDS does not meet primary endpoint

Keytruda receives two new approvals in Japan

Imugene begins phase I study of IMU-201 in NSCLC

Early clinical reports suggest utility of Aggrastat for COVID-19-related thrombotic complications

AstraZeneca begins first-in-human study of AZD-7442 for prevention and treatment of COVID-19

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...